Send me real-time posts from this site at my email

Watchlist Update: 6-13-2019 - TDOC - Teladoc - Analyst Comments

Teladoc initiated at BofA/Merrill

Teladoc initiated with a Buy at BofA/Merrill. Bofa/Merrill analyst Allen Lutz initiated Teladoc with a Buy and $65 price target saying it is an "emerging crown jewel" with multiple industry tailwinds to drive upside. Lutz sees multiple near-term growth drivers supporting 20-30% organic growth through 2020 including utilization, behavioral health, Medicare Advantage, international, and TRICARE, United Health, and new clients. The analyst sees a favorable setup heading into 2020 given conservative revenue expectations and as some intermediate growth opportunities begin to bear fruit.

Source: (

TIGER'S TAKE:  On our trading list. This one has a lot of potential and has some price swings to play with/trade. A good longer-term health care holding as well.  $TDOC

$TDOC, Teladoc Health, Inc. / H1

Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal.

If you liked this article, please click the LIKE (thumbs up) button.

Feel free to leave any comments, question, or opinions.

Follow us and check back occasionally for additional articles or comments.

Welcome!!! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue